ELTX 8-K 2026-09-14

Elicio Therapeutics, Inc. (ELTX) 8-K dated 2026-09-14 — accession 0001601485-26-000058. This URL is the filing, not the ELTX hub.

Elicio Therapeutics, Inc. (ELTX) is a biotechnology company listed on US.

Elicio Therapeutics, Inc. filed a 8-K on 2026-09-14. Accession 0001601485-26-000058.

Cached items: 5.08, 8.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ELTX revenue for 2022-12-31 was $2.3M. Net income was -$38.8M. ELTX currently screens at market cap $132.3M.

Not investment advice. The ELTX SEC hub lists recent forms. The stock page is the research view.